论文部分内容阅读
肝脏是大肠癌最常见的远处转移器官 ,正确地处理肝转移是提高大肠癌总体疗效的主要措施之一。手术切除为治疗肝转移的首选 ,合理的临床分期有助于疗效的评估 ,随着相关技术的发展、并发症的减少 ,手术指征被逐步放宽 ,对手术时机掌握的认识也在发生着变化 ,某些基因及其表达产物可用于评估疗效或预后 ;肝转移不能切除的病人疗效虽差 ,但积极的肝动脉结扎或栓塞并配合区域化疗或放疗及其它综合治疗措施 ,仍能有效延长病人的生存期
The liver is the most common distant metastasis organ of colorectal cancer. Correctly handling liver metastases is one of the main measures to improve the overall curative effect of colorectal cancer. Surgical resection is the first choice for the treatment of liver metastases. A reasonable clinical staging will help evaluate the efficacy. With the development of related technologies and the reduction of complications, surgical indications are gradually relaxed, and the understanding of surgical timing is also changing. , Some genes and their expression products can be used to evaluate the efficacy or prognosis; patients with unresectable liver metastases have poor efficacy, but active hepatic artery ligation or embolization combined with regional chemotherapy or radiotherapy and other comprehensive treatment measures can effectively extend the patient Lifetime